share_log

Is Now An Opportune Moment To Examine Ingevity Corporation (NYSE:NGVT)?

Is Now An Opportune Moment To Examine Ingevity Corporation (NYSE:NGVT)?

现在是研究 Ingevity Corporation(纽约证券交易所代码:NGVT)的好时机吗?
Simply Wall St ·  2023/12/04 09:00

Ingevity Corporation (NYSE:NGVT), might not be a large cap stock, but it saw significant share price movement during recent months on the NYSE, rising to highs of US$54.65 and falling to the lows of US$37.42. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Ingevity's current trading price of US$40.72 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let's take a look at Ingevity's outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

Ingevity Corporation(纽约证券交易所代码:NGVT)可能不是一只大盘股,但最近几个月,它在纽约证券交易所的股价出现了大幅波动,升至54.65美元的高位,跌至37.42美元的低点。一些股价变动可以为投资者提供更好的机会进入该股,并有可能以较低的价格买入。需要回答的问题是,Ingevity目前的40.72美元交易价格是否反映了小盘股的实际价值?还是它目前被低估了,为我们提供了买入的机会?让我们根据最新的财务数据来看一下Ingevity的前景和价值,看看是否存在价格变动的催化剂。

See our latest analysis for Ingevity

查看我们对 Ingevity 的最新分析

What Is Ingevity Worth?

Ingevity 值多少钱?

Good news, investors! Ingevity is still a bargain right now according to my price multiple model, which compares the company's price-to-earnings ratio to the industry average. I've used the price-to-earnings ratio in this instance because there's not enough visibility to forecast its cash flows. The stock's ratio of 11.62x is currently well-below the industry average of 19.66x, meaning that it is trading at a cheaper price relative to its peers. What's more interesting is that, Ingevity's share price is quite volatile, which gives us more chances to buy since the share price could sink lower (or rise higher) in the future. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.

好消息,投资者!根据我的价格倍数模型,Ingevity目前仍然很划算,该模型将公司的市盈率与行业平均水平进行了比较。在这种情况下,我之所以使用市盈率,是因为没有足够的知名度来预测其现金流。该股的比率为11.62倍,目前远低于行业平均水平的19.66倍,这意味着与同行相比,它的交易价格更便宜。更有趣的是,Ingevity的股价波动很大,这为我们提供了更多的买入机会,因为未来股价可能会下跌(或上涨)。这是基于其较高的贝塔值,这是衡量该股相对于其他市场的走势的好指标。

What kind of growth will Ingevity generate?

Ingevity 将带来什么样的增长?

earnings-and-revenue-growth
NYSE:NGVT Earnings and Revenue Growth December 4th 2023
纽约证券交易所:NGVT 2023 年 12 月 4 日收益和收入增长

Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. Ingevity's earnings over the next few years are expected to increase by 76%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.

当你考虑购买股票时,未来前景是一个重要方面,特别是如果你是一个寻求投资组合增长的投资者。以低廉的价格收购一家前景乐观的优秀公司永远是一项不错的投资,因此,让我们也来看看该公司的未来预期。Ingevity未来几年的收益预计将增长76%,这表明未来的前景非常乐观。这应该会带来更强劲的现金流,从而提高股票价值。

What This Means For You

这对你意味着什么

Are you a shareholder? Since NGVT is currently trading below the industry PE ratio, it may be a great time to increase your holdings in the stock. With a positive profit outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as capital structure to consider, which could explain the current price multiple.

你是股东吗?由于NGVT目前的交易价格低于行业市盈率,因此现在可能是增加股票持仓的好时机。由于利润前景乐观,看来这种增长尚未完全计入股价。但是,还有其他因素需要考虑,例如资本结构,这可以解释当前的价格倍数。

Are you a potential investor? If you've been keeping an eye on NGVT for a while, now might be the time to enter the stock. Its prosperous future profit outlook isn't fully reflected in the current share price yet, which means it's not too late to buy NGVT. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed investment decision.

你是潜在的投资者吗?如果你关注NGVT已有一段时间了,那么现在可能是进入该股的时候了。其繁荣的未来利润前景尚未完全反映在当前的股价中,这意味着现在收购NGVT还为时不晚。但是,在做出任何投资决策之前,请考虑其他因素,例如其管理团队的往绩,以便做出明智的投资决策。

If you want to dive deeper into Ingevity, you'd also look into what risks it is currently facing. Our analysis shows 3 warning signs for Ingevity (1 is potentially serious!) and we strongly recommend you look at them before investing.

如果你想更深入地研究Ingevity,你还需要研究它目前面临的风险。我们的分析显示 Ingevity 有 3 个警告信号(1 个可能很严重!)我们强烈建议您在投资之前先看看它们。

If you are no longer interested in Ingevity, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

如果您对Ingevity不再感兴趣,可以使用我们的免费平台查看我们其他50多只具有高增长潜力的股票清单。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发